腎去神經支配市場規模、佔有率、成長分析、按產品、按技術、按最終用戶、按地區 - 行業預測，2025-2032 年

2023年全球去腎神經術市場規模為43364萬美元，從2024年的61013萬美元成長到2032年的937079萬美元，複合年成長率預計將保持在40.7%。

由於高血壓盛行率不斷上升，以及人們越來越意識到去腎神經術作為微創治療的好處，全球去腎神經術市場正在強勁成長。這種治療方法可以有效阻斷腎臟神經來調節血壓，對患者和醫療保健提供者很有吸引力，因為它有可能減少藥物依賴性並改善患者的治療結果。技術進步，例如利用射頻和超音波能量的創新導管系統，正在提高手術的準確性和安全性，並進一步促進採用。然而，挑戰仍然存在，包括需要長期臨床資料來檢驗療效以及保險報銷的障礙。儘管存在這些障礙，去腎神經市場預計將繼續擴大，隨著對有效高血壓治療的需求不斷成長，為醫療設備創新者提供了充滿希望的機會。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 案例研究
• 技術進步

腎去神經術市場規模：依產品及複合年成長率（2025-2032）

• 市場概況
• 簡單
• 基礎知識（V2）
• 開導
• 天堂
• 伊貝里斯
• 其他

腎去神經術市場規模：依技術及複合年成長率（2025-2032）

• 市場概況
• 無線電頻率
• 超音波
• 微量輸液
• 其他

腎去神經術市場規模：依最終用戶和複合年成長率（2025-2032）

• 市場概況
• 醫院
• 診所
• 門診手術中心
• 其他

腎去神經術市場規模：按地區和複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Medtronic（Ireland）
• Symap Medical（China）
• Shanghai Golden Leaf Medtec（China）
• Shanghai Wisegain Medical Devices（China）
• Terumo Corporation（Japan）
• Abbott Laboratories（USA）
• Johnson & Johnson（USA）
• Boston Scientific（USA）
• St. Jude Medical（USA）
• Cordis Corporation（USA）
• Vessix Vascular（USA）
• Ardian（USA）
• Otsuka Holdings（Japan）

結論和建議

Global Renal Denervation Market size was valued at USD 433.64 million in 2023 and is poised to grow from USD 610.13 million in 2024 to USD 9370.79 million by 2032, growing at a CAGR of 40.7% during the forecast period (2025-2032).

The global renal denervation market is experiencing robust growth, driven by the rising prevalence of hypertension and increasing awareness of renal denervation's benefits as a minimally invasive treatment. This procedure effectively disrupts renal nerves to regulate blood pressure, appealing to patients and healthcare providers alike due to its potential to reduce dependence on medications and enhance patient outcomes. Technological advancements, including innovative catheter systems utilizing radiofrequency or ultrasound energy, have improved the procedure's precision and safety, further promoting adoption. However, challenges remain, such as the need for more long-term clinical data to validate efficacy and reimbursement barriers. Despite these obstacles, the renal denervation market is poised for continued expansion, offering lucrative opportunities for medical device innovators as demand for effective hypertension treatments grows.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Renal Denervation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Renal Denervation Market Segmental Analysis

Global Renal Denervation Market is segmented by product, technology, end-users and region. Based on product, the market is segmented into simplicity, vessix (V2), enlightn, paradise, iberis and others. Based on technology, the market is segmented into radiofrequency, ultrasound, micro-infusion and others. Based on end-users, the market is segmented into hospital, clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Renal Denervation Market

The Global Renal Denervation market is significantly propelled by technological advancements that enhance the effectiveness and safety of the procedure. Innovations in catheter designs, enhanced energy delivery systems, and the development of novel nerve-modifying agents are all contributing to this growth. These improvements not only increase the precision of renal denervation but also expand its clinical applications, leading to better patient outcomes. As these technologies continue to evolve, they are making renal denervation a more viable treatment option for patients with resistant hypertension, ultimately driving greater adoption and expansion of this market on a global scale.

Restraints in the Global Renal Denervation Market

The Global Renal Denervation market faces several restraints, particularly due to limited awareness and adoption in emerging markets. In these regions, the understanding of renal denervation as a viable treatment for hypertension is often minimal, which hinders its acceptance among both healthcare providers and patients. Furthermore, inadequate healthcare infrastructure exacerbates this issue, restricting access to advanced medical treatments and technologies. As a result, the growth potential of the renal denervation market in these areas is significantly constrained, as efforts to educate stakeholders and improve healthcare services are still underway. These challenges must be addressed to facilitate market expansion.

Market Trends of the Global Renal Denervation Market

The Global Renal Denervation market is witnessing a significant shift towards ambulatory settings, where procedures are increasingly performed on an outpatient basis rather than in traditional hospital environments. This trend is propelled by the dual benefits of cost-effectiveness and patient convenience, as outpatient procedures reduce hospitalization times and associated costs. Enhanced accessibility to renal denervation techniques in ambulatory settings not only democratizes patient care but also stimulates market growth by attracting a broader patient demographic seeking less invasive treatment options. As healthcare systems evolve and prioritize outpatient care, this trend is poised to reshape the landscape of renal denervation therapies globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Renal Denervation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Simplicity
• Vessix (V2)
• Enlightn
• Paradise
• Iberis
• Others

Global Renal Denervation Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency
• Ultrasound
• Micro-Infusion
• Others

Global Renal Denervation Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospital
• Clinics
• Ambulatory Surgery Centers
• Others

Global Renal Denervation Market Size & CAGR (2025-2032)

• North America (Product, Technology, End-Users)
  • US
  • Canada
• Europe (Product, Technology, End-Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, End-Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, End-Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, End-Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Symap Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Golden Leaf Medtec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Wisegain Medical Devices (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vessix Vascular (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardian (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations